EXOSOMES

Exosomes are nanoscale extracellular vesicles, tiny biological packages that cells use to communicate with each other. They are not a synthetic product. They are a fundamental part of how the body coordinates cellular behaviour, repair, and regeneration. In the context of aesthetic medicine, the exosomes we use at Juvenology are derived from mesenchymal stem cells grown in controlled laboratory conditions. The stem cells are cultured, the exosomes they produce are harvested, concentrated, and rigorously quality-tested before being used in treatment. The sophistication of exosomes lies in what they carry. Unlike PRP, which delivers a broad release of growth factors, exosomes contain a precisely targeted payload of signalling molecules that direct specific repair processes at a molecular level.

Exosomes work at a level of biological precision that no other aesthetic treatment currently matches. When delivered into the dermis, they are absorbed by surrounding cells and release their cargo directly inside those cells. That cargo includes growth factors, messenger RNA sequences, microRNA, proteins, and lipids, each directing specific cellular processes. The result is a regenerative response that operates at a depth and specificity that other treatments do not achieve. Where polynucleotides stimulate cellular repair through DNA-level signalling and PRP delivers growth factors from your own platelets, exosomes direct the repair process with a precision that reflects their role as the body's own cellular communication system.

Exosomes are particularly valuable for concerns where the underlying biology requires more than surface correction or general biostimulation, where the cellular machinery itself needs to be directed to repair and regenerate rather than simply encouraged. They are also increasingly used as a post-treatment adjunct, applied immediately after microneedling when the dermal channels are temporarily open, to maximise delivery and uptake of the regenerative payload.

At Juvenology, exosomes are delivered into the dermis via microneedling immediately after the needling treatment is complete. This sequencing is clinically deliberate and scientifically important. Microneedling creates thousands of microscopic channels through the epidermis and into the dermis. For a short window after treatment, these channels remain open, bypassing the epidermal barrier that would otherwise limit how much of any topically applied product can penetrate. Applying exosomes directly into this window maximises their delivery to the dermal layer where they need to be. The redness following treatment is not damage. It is the visible sign of the repair cascade that is now underway in your dermis. It is expected and temporary.

The appropriate number of sessions depends on the concern being treated, the severity of the skin changes, and the individual's biological response to treatment. Results develop progressively over weeks following each session as the cellular repair processes initiated by the exosomes complete their work. The most significant improvements are typically visible at the two to three month mark following a full course of treatment, continuing to develop beyond that as collagen remodelling completes. This is a different timeline from fillers and anti-wrinkle injections, and understanding it prevents disappointment in the early weeks.

Exosome results develop gradually, reflecting genuine biological regeneration rather than an immediate mechanical or volumetric change. The improvements patients describe are qualitative as much as visual. Skin that feels more resilient. That recovers from environmental stressors more quickly. That holds hydration better. That looks more even in tone and more vital in texture. These are not cosmetic impressions. They are the visible consequence of tissue that has genuinely regenerated at the cellular level.

Exosomes have a growing and rapidly developing evidence base and a strong emerging safety profile in aesthetic medicine. The clinical results in patients with photoageing, scarring, and inflammatory skin conditions have been consistently promising. Because exosomes are derived from donor stem cells rather than the patient's own cells, product selection, provenance, quality control, and storage integrity are critical. This is not an area where I compromise. All contraindications are assessed thoroughly at your initial consultation. If exosomes are not appropriate for your individual circumstances, we will identify an alternative regenerative approach that is.

Both PRP and exosomes are regenerative treatments that work by delivering biological signals into the tissue. The differences lie in the source of those signals, the precision of the delivery, and the breadth of the biological effect. PRP remains an excellent treatment with a well-established evidence base and the significant advantage of using your own biology with zero allergy risk. Exosomes offer a more targeted and sophisticated regenerative signal. For patients with more complex concerns, or those who have not achieved the response they hoped for from PRP alone, exosomes represent a meaningful step forward in regenerative capability.

Yes, and in most cases combining exosomes with other treatments produces better outcomes than using them in isolation. The most powerful combination for patients with significant photoageing or acne scarring is microneedling with exosomes, potentially alongside PRP for the growth factor amplification effect. The sequencing and combination that is right for your specific concern and skin biology is determined at consultation. There is no universal protocol that applies to every patient, and pretending otherwise produces results that disappoint.

Exosomes represent a genuinely different category of regenerative treatment, not an incremental improvement on what exists but a fundamentally different mechanism of action that operates at a level of biological precision no other aesthetic treatment currently matches. But this distinction also makes product quality more critical here than in almost any other aesthetic treatment. Not all exosome products on the market meet these standards. The aesthetic industry has moved faster than the regulatory framework in some areas, and exosomes are one of them. At Juvenology, I am selective about which exosome products I use and I do not compromise on provenance, quality control, or storage integrity regardless of cost or convenience. The difference between a well-manufactured, rigorously quality-controlled exosome product and a poorly characterised one is the difference between a genuine regenerative effect and an expensive placebo. This is why, when you book exosome treatment at Juvenology, the product conversation is part of the clinical assessment. Not a marketing discussion. A clinical one.